PhRMA Says Drug Prices Would be Lower if Pharmacy Benefit Managers Were Paid Differently

The Pharmaceutical Research and Manufacturers of America (PhRMA) recently proposed a new policy for how pharmacy benefit managers (PBMs) and others in the supply chain should be compensated for their work. The biopharmaceutical industry trade group says that if PBMs were paid a service fee instead of the current process wherein they’re given a percentage of a drug’s list price, then the overall cost of prescription medications in the US would go down.